logo

OCTOBER 29-NOVEMBER 2, 2017
COLORADO CONVENTION CENTER
DENVER, COLORADO

Embargo Policy for TCT 2017

Please note that press conference presentations of late-breaking trials and first report investigations at TCT are held prior to the Main Arena presentations as a courtesy to the media. Embargoes do not lift until the start time of each individual main arena presentation, as listed in the TCT agenda. All embargo times will be listed in Mountain Time (MT).

Schedule Coming Soon.

Sunday, October 30, 2016

7:30 am - 9:00 am

Moderator: Ajay J. Kirtane, MD, SM

Discussants: Dean J. Kereiakes, MD; Neal S. Kleiman, MD; Paul S. Teirstein, MD

 

7:30 am

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs. IVUS-Guided vs. Angio-Guided Stent Implantation in Patients with Coronary Artery Disease

Ziad A. Ali, MD DPhil

Embargo Lift Time: 9:00 am 

7:45 am

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients with Coronary Artery Disease

Clemens von Birgelen, MD, PhD

Embargo Lift Time: 9:20 am 

8:00 am

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs. a Zotarolimus-Eluting Stent in a More-Comers Population of Patients with Coronary Artery Disease

David E. Kandzari, MD

Embargo Lift Time: 9:40 am 

8:15 am

ABSORB China: Two-Year Clinical Outcomes from a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs. an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Runlin Gao, MD

Embargo Lift Time: 12:15 pm 

8:30 am

ABSORB II: Three-Year Clinical Outcomes from a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs. an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Patrick W. Serruys, MD, PhD

Embargo Lift Time: 12:30 pm 

8:45 am

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes from a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients with Coronary Artery Disease at High Bleeding Risk

Philip M. Urban, MD

Embargo Lift Time: 12:45 pm  

 

Monday, October 31, 2016

7:30 am - 9:15 am

Moderator: Roxana Mehran, MD

Discussants: David J. Cohen, MD, MSc; Dean J. Kereiakes, MD; Michael J. Mack, MD

 

7:30 am

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients with Left Main Coronary Artery Disease

Gregg W. Stone, MD

Embargo Lift Time: 9:00 am 

7:45 am

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients with Left Main Coronary Artery Disease

Evald H. Christiansen, MD, PhD

Embargo Lift Time: 9:15 am 

8:00 am

REVELUTION: 9-Month Clinical, Angiographic, IVUS, and OCT Outcomes with a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Stephen G. Worthley, MBBS, PhD

Embargo Lift Time: 12:00 pm 

8:15 am

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Alexandre Abizaid, MD, PhD

Embargo Lift Time: 12:13 pm 

8:30 am

MeRes-1: 6-Month Clinical, Angiographic, IVUS and OCT Results with a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease

Ashok Seth, MBBS, DSc, DLitt

Embargo Lift Time: 12:21 pm 

8:45 am

FORTITUDE: 9-Month Clinical, Angiographic, and OCT Results with an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease

Antonio Colombo, MD

Embargo Lift Time: 12:29 pm 

9:00 am

FUTURE-I: 6-Month Clinical, Angiographic, IVUS and OCT Results with a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease

Xu Bo, MBBS

Embargo Lift Time: 12:37 pm 

 

Tuesday, November 1, 2016

7:30 am - 9:30 am

Moderator: George D. Dangas, MD, PhD

Discussants: David R. Holmes Jr., MD; Jeffrey J. Popma, MD; Craig M. Walker, MD

 

7:30 am

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Susheel Kodali, MD

Embargo Lift Time: 9:00 am 

7:45 am

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate Risk Patients with Severe Aortic Stenosis

David J. Cohen, MD, MSc

Embargo Lift Time: 9:20 am 

8:00 am

PARTNER I FIVE-YEAR ECHO: Long-Term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients with Aortic Stenosis

Pamela S. Douglas, MD

Embargo Lift Time: 9:40 am 

8:15 am

RESPECT; Final Long-Term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients with Cryptogenic Stroke

David E. Thaler, MD, PhD

Embargo Lift Time: 12:15 pm 

8:30 am

COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes after Stent Implantation in Patients with Coronary Artery Disease

Giora Weisz, MD

Embargo Lift Time: 12:30 pm

8:45 am

PLATINUM DIVERSITY: Outcomes from a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

Wayne B. Batchelor, MD, MHS

Embargo Lift Time: 12:45 pm 

9:00 am

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

Hiroki Shiomi, MD

Embargo Lift Time: 1:00 pm

9:15 am

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results with a Left Atrial Appendage Closure Device for Stroke Prevention in Patients with Atrial Fibrillation

Vivek Y. Reddy, MD

Embargo Lift Time: NOTE: The WATCHMAN US POST-APPROVAL STUDY Press conference is the day before its embargo lift and presentation time on Wednesday, November 2 at 9:20 am 

 

Wednesday, November 2, 2016

7:30 am - 9:00 am

Moderator: Ori Ben-Yehuda, MD

Discussants: William A. Gray, MD; Jonathan M. Hill, MD; Christopher Metzger, MD

 

7:30 am

ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries

Sean P. Lyden, MD

Embargo Lift Time: 9:00 am 

7:45 am

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results with a Left Atrial Appendage Closure Device for Stroke Prevention in Patients with Atrial Fibrillation

David Hildick-Smith, MD

Embargo Lift Time: 9:40 am 

8:00 am

PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients with Coronary Artery Chronic Total Occlusions

Koen Teeuwen, MD

Embargo Lift Time: 12:15 pm

8:15 am

TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients with Coronary Artery Chronic Total Occlusions

Christopher E. Buller, MD

Embargo Lift Time: 12:30 pm 

8:30 am

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at 3 Months and Neoatherosclerosis at 18 Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Giulio Guagliumi, MD

Embargo Lift Time: 12:45 pm 

8:45 am

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis – 6-9 Month Clinical and Angiographic Follow-up Results

Fernando Alfonso, MD, PhD

Embargo Lift Time: 1:00 pm